Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies

Clinical trial NCT01206777 · COMPLETED

Trial details

NCT number: NCT01206777
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent or Intermediate Grade B-cell Malignancy

Start date: 2010-10-01
Primary completion: 2013-04-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.